| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |